Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sanyal

Showing results (1-10 of 686) with videos related to

Pageof 69
Sort By:
Hepatology International|July 24, 2015
An integrated view of liver injury and disease progression in nonalcoholic steatohepatitisArun J Sanyal
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Use of farnesoid X receptor agonists to treat nonalcoholic fatty liver diseaseArun J Sanyal
Nature Reviews. Gastroenterology & Hepatology|April 27, 2019
Past, present and future perspectives in nonalcoholic fatty liver diseaseArun J Sanyal
Alimentary Pharmacology & Therapeutics|October 18, 2005
Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implicationsA J Sanyal
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis CArun J Sanyal
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver diseaseArun J Sanyal
Clinics and Research in Hepatology and Gastroenterology|July 11, 2015
Novel therapeutic targets for steatohepatitisArun J Sanyal
Seminars in Gastrointestinal Disease|November 14, 1997
The management of the cirrhotic patient after transjugular intrahepatic portosystemic shuntA J Sanyal
Current Gastroenterology Reports|September 12, 2000
The use and misuse of transjugular intrahepatic portasystemic shuntsA J Sanyal
BMC Medicine|August 25, 2018
Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?Arun J Sanyal
Pageof 69

Showing results (1-10 of 686) with videos related to

Sort By:
Pageof 69
Hepatology International|July 24, 2015
An integrated view of liver injury and disease progression in nonalcoholic steatohepatitisArun J Sanyal
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Use of farnesoid X receptor agonists to treat nonalcoholic fatty liver diseaseArun J Sanyal
Nature Reviews. Gastroenterology & Hepatology|April 27, 2019
Past, present and future perspectives in nonalcoholic fatty liver diseaseArun J Sanyal
Alimentary Pharmacology & Therapeutics|October 18, 2005
Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implicationsA J Sanyal
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis CArun J Sanyal
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver diseaseArun J Sanyal
Clinics and Research in Hepatology and Gastroenterology|July 11, 2015
Novel therapeutic targets for steatohepatitisArun J Sanyal
Seminars in Gastrointestinal Disease|November 14, 1997
The management of the cirrhotic patient after transjugular intrahepatic portosystemic shuntA J Sanyal
Current Gastroenterology Reports|September 12, 2000
The use and misuse of transjugular intrahepatic portasystemic shuntsA J Sanyal
BMC Medicine|August 25, 2018
Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?Arun J Sanyal
Pageof 69